Rūta Pumputienė Law Firm has been listed as a Life Sciences legal firm in the categories of regulatory and product liability Who’s Who Legal in 2018. Rūta Pumputienė is one

Rūta Pumputienė, Head of the Local American Working Group (LAWG), was quoted on the news website 15min.lt article in the Business section. She commented the availability of innovative medicines in

“Calling the past two years ‘eventful’ for the Lithuanian Ministry of Health and the Lithuanian healthcare sector in general would be an understatement. <…>” “The present-day issues are, of course,

R. Pumputienė notes what we need to know about the special categories of data in the new era of the pharmaceutical industry. For example, due to the GDPR, special attention

Lithuania’s healthcare and Life Sciences sector is enjoying an ever-increasing role in the national economy. Today, it accounts for roughly four percent of the GDP, with a somewhat surprising one

At one of the most important events in the Lithuanian pharmaceutical industry, the Healthcare Innovation Forum, health policymakers, scientists, representatives of the pharmaceutical industry, doctors, representatives of public institutions and

Her commentary “Fight against falsified medicines: relevant medicine control developments” was published in the daily Lietuvos žinios. “One of the essential innovations is a unique identifier on the ingredients (with

“The Lithuanian decision makers must first set clear priorities for the future five, 10 and 15 years in advance, priorities that focus on the reversal of the Lithuanian healthcare specialist

Rūta Pumputienė, Head of the Local American Working Group (LAWG), during the interview with PharmaBoardroom, explained the main dynamics impacting the pharmaceutical sector in general, as well as the key

After the report released by the Ministry of Health on the growing budget for the Compulsory Health Insurance, R. Pumputienė has identified the problems that require the attention of policymakers.